Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 14/20 | 0.48 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.48 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.37 |
| ▸ | POLA1 | P09884 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | GMNN | O75496 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15747 | 0.77 | CYP2C19 (0.70) | CYP2C19LMNAHIF1APOLA1HTT | |
| Apaxifylline SCHEMBL194999 | 0.69 | ADORA1 (1.00) | ADORA1ADORA2AADORA2BADORA3LMNA | |
| Apaxifylline SCHEMBL194806 | 0.69 | ADORA1 (1.00) | ADORA1ADORA2AADORA2BADORA3LMNA | |
| SCHEMBL4983391 | 0.63 | ADORA1 (0.70) | ADORA1ADORA2AADORA2BADORA3LMNA | |
| Hydrochloric Acid SCHEMBL29351943 | 0.63 | CYP2C19 (0.98) | CYP2C19LMNAHIF1APOLA1HTT | |
| SCHEMBL9729348 | 0.62 | ADORA1 (0.83) | ADORA1ADORA2AADORA2BADORA3LMNA | |
| SCHEMBL9728748 | 0.62 | ADORA1 (0.83) | ADORA1ADORA2AADORA2BADORA3LMNA | |
| SCHEMBL9728826 | 0.62 | ADORA1 (0.83) | ADORA1ADORA2AADORA2BADORA3LMNA | |
| SCHEMBL9728743 | 0.62 | ADORA1 (0.83) | ADORA1ADORA2AADORA2BADORA3LMNA | |
| SCHEMBL8873114 | 0.62 | ADORA1 (0.83) | ADORA1ADORA2AADORA2BADORA3LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120264605-A1 | Multi-Functional Ionic Liquid Compositions for Overcoming Polymorphism and Imparting Improved Properties for Active Pharmaceutical, Biological, Nutritional, and Energetic Ingredients | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2012-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120264605-A1 | Multi-Functional Ionic Liquid Compositions for Overcoming Polymorphism and Imparting Improved Properties for Active Pharmaceutical, Biological, Nutritional, and Energetic Ingredients | SLC5A6, PNLIP, IPMK | ADORA1 323/4885ADORA2A 561/4885ADORA2B 664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.